KIR2DL3 and cervical carcinoma: As HPV+ invasive cervical cancer patients display upregulation in HLA-C/KIR2DL2 and HLA-C/KIR2DL3 antigen pairs (13), enhancing the HLA-C/KIR interaction may suppress normal NK cell function in HPV+ cervical cancer patients.